News
MENS
2.030
+3.05%
0.060
Weekly Report: what happened at MENS last week (0921-0925)?
Weekly Report · 1d ago
Weekly Report: what happened at MENS last week (0914-0918)?
Weekly Report · 09/21 09:04
Weekly Report: what happened at MENS last week (0907-0911)?
Weekly Report · 09/14 09:04
Weekly Report: what happened at MENS last week (0831-0904)?
Weekly Report · 09/07 09:04
Weekly Report: what happened at MENS last week (0824-0828)?
Weekly Report · 08/31 09:04
Weekly Report: what happened at MENS last week (0817-0821)?
Weekly Report · 08/24 09:05
Weekly Report: what happened at MENS last week (0810-0814)?
Weekly Report · 08/17 09:05
Weekly Report: what happened at MENS last week (0803-0807)?
Weekly Report · 08/10 09:04
Weekly Report: what happened at MENS last week (0727-0731)?
Weekly Report · 08/03 09:04
Weekly Report: what happened at MENS last week (0720-0724)?
Weekly Report · 07/27 09:04
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
Barchart · 07/23 09:52
Weekly Report: what happened at MENS last week (0713-0717)?
Weekly Report · 07/20 09:04
Weekly Report: what happened at MENS last week (0706-0710)?
Weekly Report · 07/13 09:04
Weekly Report: what happened at MENS last week (0629-0703)?
Weekly Report · 07/06 09:05
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 06/29 21:05
Weekly Report: what happened at MENS last week (0622-0626)?
Weekly Report · 06/29 09:04
Weekly Report: what happened at MENS last week (0615-0619)?
Weekly Report · 06/22 09:05
Weekly Report: what happened at MENS last week (0608-0612)?
Weekly Report · 06/15 09:05
Weekly Report: what happened at MENS last week (0601-0605)?
Weekly Report · 06/08 09:05
Weekly Report: what happened at MENS last week (0525-0529)?
Weekly Report · 06/01 09:05
More
Webull provides a variety of real-time MENS stock news. You can receive the latest news about Jyong Biotech Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About MENS
Jyong Biotech Ltd is a Taiwan-based science-driven biotechnology company. The Company is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The Company has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.